SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001999371-24-001668
Filing Date
2024-02-07
Accepted
2024-02-07 17:19:44
Documents
14
Period of Report
2024-02-06
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT dmk_8k-020624.htm   iXBRL 8-K 26024
  Complete submission text file 0001999371-24-001668.txt   198236

Data Files

Seq Description Document Type Size
2 XBRL PRESENTATION FILE dmk-20240206_pre.xml EX-101.PRE 22360
3 XBRL SCHEMA FILE dmk-20240206.xsd EX-101.SCH 3015
4 XBRL LABEL FILE dmk-20240206_lab.xml EX-101.LAB 34240
15 EXTRACTED XBRL INSTANCE DOCUMENT dmk_8k-020624_htm.xml XML 3595
Mailing Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130
Business Address 11682 EL CAMINO REAL SUITE 300 SAN DIEGO CA 92130 (858) 997-2400
DMK PHARMACEUTICALS Corp (Filer) CIK: 0000887247 (see all company filings)

IRS No.: 820429727 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36242 | Film No.: 24605857
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)